We are live on ! Find out more
RDHL

Redhill Biopharma
RDHL

21 hedge funds and large institutions have $33.1M invested in Redhill Biopharma in 2015 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% less funds holding

Funds holding: 22 → 21 (-1)

10% less capital invested

Capital invested by funds: $36.9M → $33.1M (-$3.82M)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

Holders
21
Holders Change
-1
Holders Change %
-4.55%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$174K
2
Walleye Trading
Walleye Trading
New York
+$37.3K
3
VanEck Associates
VanEck Associates
New York
+$12.4K

Top Sellers

Rank Fund Capital Flow
1
AIC
AWM Investment Company
New York
-$3.48M
2
BHB
Bank Hapoalim BM
Israel
-$224K
3
Millennium Management
Millennium Management
New York
-$178K
4
SM
Sabby Management
Florida
-$174K
5
FAM
Fred Alger Management
New York
-$99.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
BC
1
Broadfin Capital
New York
$10.7M – – –
O
2
OrbiMed
New York
$7.28M – – –
VAM
3
Visium Asset Management
New York
$6.44M – – –
MMH
4
Menora Mivtachim Holdings
Israel
$3.17M – – –
SM
5
Sabby Management
Florida
$2.06M -$174K -14 -8%
CS
6
Candriam SCA
Luxembourg
$914K – – –
BHB
7
Bank Hapoalim BM
Israel
$709K -$224K -18 -25%
FAM
8
Fred Alger Management
New York
$425K -$99.5K -8 -20%
NC
9
Nexthera Capital
New York
$309K +$299K +24 New
Royal Bank of Canada
10
Royal Bank of Canada
Ontario, Canada
$270K – – –
Morgan Stanley
11
Morgan Stanley
New York
$196K +$174K +14 +1,400%
FM
12
Family Management
New York
$187K -$87.1K -7 -32%
VanEck Associates
13
VanEck Associates
New York
$121K +$12.4K +1 +13%
PVH
14
Psagot Value Holdings
Israel
$91K -$12.4K -1 -13%
Wells Fargo
15
Wells Fargo
California
$52K – – –
MMG
16
Monetary Management Group
Missouri
$50K – – –
Walleye Trading
17
Walleye Trading
New York
$44K +$37.3K +3 New
UBS Group
18
UBS Group
Switzerland
$26K – – –
Bank of America
19
Bank of America
North Carolina
$13K – – –
WA
20
WFG Advisors
Texas
$9K – – –
MSFP
21
Mark Sheptoff Financial Planning
Connecticut
$6K – – –
TWA
22
TCI Wealth Advisors
Arizona
$5K – – –
AIC
23
AWM Investment Company
New York
– -$3.48M -270 Closed
Millennium Management
24
Millennium Management
New York
– -$178K -14 Closed
TRCT
25
Tower Research Capital (TRC)
New York
– -$16K -1 Closed
1
2

RDHL Hedge Fund Activity: Q4 2015 in Review

21 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q4 2015, worth a combined $33.1M — down 10% from $36.9M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of RDHL and 2 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 2 added.

The largest buyer was Morgan Stanley, adding an estimated $174K. The largest seller was AWM Investment Company, exiting entirely with an estimated $3.48M sold.

  • 21 institutional investors held Redhill Biopharma (RDHL) as of Q4 2015, down from 22 in Q3 2015.
  • Funds reported $33.1M of Redhill Biopharma stock for Q4 2015, down 10% quarter-over-quarter.
  • 2 funds opened new Redhill Biopharma positions in Q4 2015 and 3 closed out, a net change of -1 holder.
  • The largest Redhill Biopharma buyer in Q4 2015 was Morgan Stanley, an estimated $174K added.
  • The largest Redhill Biopharma seller in Q4 2015 was AWM Investment Company, an estimated $3.48M sold.

Based on aggregated 13F filings for Q4 2015.